ArticleBMC psychiatry2024
ADHD medicine consumption in Europe after COVID-19: catch-up or trend change?
Article in BMC psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Misinformation mayhem: the effects of TikTok content on ADHD knowledge, stigma, and treatment-seeking intentions.European child & adolescent psychiatry · 2025Trial
- Incidence, prevalence, and global burden of attention-deficit/hyperactivity disorder from 1990 to 2021 across 204 countries in individuals under age 20: data, with critical appraisal, from the 2021 Global Burden of Disease study.Molecular psychiatry · 2026Article
- Prescribing trends and spontaneous reporting patterns of adverse drug reactions of ADHD medications in children and adolescents in germany: A retrospective analysis (2013-2022).European child & adolescent psychiatry · 2026Article
- The exponential increase in the number of prescriptions for ADHD medication between 2012 and 2022 in Poland in patients aged 5-59 years: a pharmacoepidemiological study.European child & adolescent psychiatry · 2026Article
- Prescribing medications for attention-deficit/hyperactivity disorder in children: a retrospective analysis of a Japanese health insurance claims database.BMC psychiatry · 2026Article
- Trends and incidence rates of neurodevelopmental disorders in Danish children and adolescents 2000-2024 : Short title: neurodevelopmental disorders in children and adolescents.European child & adolescent psychiatry · 2026Article
- Patterns of prescription stimulant initiation before and during the COVID-19 pandemic: a population-based time-series analysis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026Article
- Trends in use of Attention-Deficit Hyperactivity Disorder medications among children and adults in five European countries, 2010 to 2023: a population-based observational study.The Lancet regional health. Europe · 2026Article
- The trends in the use of psychopharmacological medications in Ukraine 2010-2022.BMC psychiatry · 2026Article
- ADHD medication dispensing trends in Dutch youth before and after the implementation of the Youth Act (2010-2022).European child & adolescent psychiatry · 2025Article
- Sex differences in self-reported attention-deficit/hyperactivity disorder symptoms in clinical and population-based cohorts.JCPP advances · 2025Article
- Global Trends in ADHD Medication Use: Multiple Contexts and Rising Concerns-A Narrative Review.Journal of clinical medicine · 2025Review
- Wearables in ADHD: Monitoring and Intervention-Where Are We Now?Diagnostics (Basel, Switzerland) · 2025Review
- Impact of COVID-19 pandemic policies on ADHD medication prescriptions among children and adolescents in Portugal.European journal of pediatrics · 2025Article
- Online interest in ADHD predicts ADHD medication prescriptions in Australia from 2004 to 2023: A time-series analysis revealing COVID-19-related acceleration.Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists · 2025Article
- Transitioning From Pediatric to Adult Psychiatric Care for ADHD in Sweden: A Nationwide Study.Journal of attention disorders · 2025Observational
- Prescription drug use in Danish children and adolescents 2005-2023.European journal of epidemiology · 2025Article
- Seasonal trends in methylphenidate use: A mirror of misuse or compliance?The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2025Article
- Prevalence and associated factors of ADHD-like symptoms among pharmacy students at Prince of Songkla University, Thailand in 2024: a cross-sectional study.Ewha medical journal · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough the COVID-19 pandemic and its implications have been associated with mental health services utilization and medication consumption, there is no longitudinal study on the long-term impact on ADHD medication use trends.
methodsThis study examines the European ADHD medication consumption in 2020 to 2022 compared to the predicted consumption assuming the persistence of pre-pandemic trends. Predictions are calculated using Seasonal Autoregressive Integrated Moving Average (SARIMA) models.
resultsWhile European ADHD medication sales recorded a drop in 2020, they returned to the predicted level in 2021, even slightly exceeding it. In 2022, we found a clear exceedance of the predicted level by 16.4% on average at country level. Furthermore, the increase in consumption growth in the post-pandemic period (2021-2022) compared to the pre-pandemic period (2014-2019) was significant in 26 of the 28 European countries under consideration.
conclusionThere is strong evidence of a trend change in the ADHD medicine consumption growth throughout Europe after the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.